The genetically modified Bacillus subtilis SCK6 strain BsS-RS06550 showed beneficial effects toward obesity, fasting blood glucose, insulin resistance, hepatic steatosis and fat accumulation. This evidence concerns the gene INS and Hepatic steatosis.